Close
Nordic 9Nordic 9

Martin Tromp Permin (investor - Angel Investor)

Denmark
See something wrong or missing? Let us know
Offices:Copenhagen

Martin Permin is a CEO at Pelion in the USA.

Average round investment:1M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: Denmark Reshape Biotech
Mostly invests in: Denmark Denmark (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Martin Tromp Permin

Name Criteria
Denmark Nicholas Francis
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark Mads Ingwar
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Gerhard Dal
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Funders Club
76%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Denmark Syddansk Innovation (SDTI)
76%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 3.5
  • Active last 12 months: Yes
Sweden Porte-Monnaie
75%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Norway Stratel AS
72%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Finland Springvest Oy
72%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Finland Leena Niemistö
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Denmark Spring Nordic
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top